What is the safety of peritoneal dialysis (PD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Peritoneal Dialysis

Peritoneal dialysis is a safe and effective renal replacement therapy when properly implemented, with centers achieving 75% 2-year technique survival rates, though infectious complications—particularly peritonitis—remain the primary safety concern affecting morbidity, mortality, and technique failure. 1

Key Safety Outcomes

Technique Survival and Overall Safety

  • Centers should strive to achieve a 75% 2-year technique survival rate, which represents the benchmark established in major clinical studies. 1
  • PD technique survival depends on multiple factors including infections, patient motivation, ultrafiltration capacity, and adequate solute clearance. 1
  • Approximately 16% of patients experience technique failure due to peritonitis, requiring transfer to hemodialysis. 2

Hospitalization Rates

  • PD patients average 1.8 hospitalizations per year, which serves as an important safety and effectiveness indicator. 1
  • Hospitalizations can be ESRD-related (peritonitis, catheter infections, hernias, leaks) or ESRD-unrelated (cardiovascular, other infections). 1
  • Low creatinine clearance is associated with increased hospitalization rates and prolonged hospital stays. 1

Primary Safety Concerns

Infectious Complications

Peritonitis remains the most serious safety threat in PD, with reported rates of 0.24-1.66 episodes per patient-year, though quality standards demand rates below 0.67 episodes per patient-year. 3

Impact on Mortality and Morbidity

  • For every 0.5-per-year increase in peritonitis rate, mortality risk increases by 4%. 3
  • 18% of peritonitis episodes result in catheter removal. 3
  • 3.5% of peritonitis episodes result in death. 3
  • Frequent peritonitis causes severe malnutrition through excessive protein losses, further increasing mortality and morbidity. 2

Common Causative Organisms

  • Gram-positive cocci (Staphylococcus epidermidis, coagulase-negative staphylococci, S. aureus) are the most frequent causes worldwide. 3
  • Candida species are the most common fungal cause. 2
  • Aspergillus species also cause peritonitis, though less frequently. 2

Management of Fungal Peritonitis

  • Catheter removal is mandatory for fungal peritonitis, along with antifungal treatment for minimum 3 weeks and transfer to hemodialysis. 3

Exit-Site and Tunnel Infections

  • These infections increase risk of peritonitis and technique failure. 3, 4
  • Mupirocin prophylaxis can reduce exit-site infection risk by 46%, though it does not decrease overall peritonitis risk. 3

Mechanical Complications

Mechanical complications, while less life-threatening than infections, can lead to technique failure if not properly managed. 5

  • Hernias and peritoneal leaks occur more frequently with larger instilled dialysate volumes. 1
  • Inadequate ultrafiltration can result from high peritoneal transport characteristics or catheter mechanical defects. 2
  • Abdominal wall defects are significantly associated with previous abdominal surgery history. 5

Encapsulating Peritoneal Sclerosis (EPS)

  • EPS is a rare but serious complication with high morbidity and 20% mortality rate. 5
  • Risk increases with duration of PD treatment. 5
  • Diagnosis requires high index of suspicion based on clinical symptoms; no reliable early screening tests exist. 5
  • Surgical enterolysis is the only established treatment; conservative management should not delay definitive intervention. 5

Contraindications to PD

Absolute Contraindications

  • Documented loss of peritoneal function or extensive abdominal adhesions limiting dialysate flow. 6
  • Physical or mental inability to perform PD without suitable assistant. 6
  • Uncorrectable mechanical defects (irreparable hernias, omphalocele, gastroschisis, diaphragmatic hernia, bladder exstrophy). 6

Relative Contraindications

  • Recently implanted intra-abdominal foreign bodies (require 4-month waiting period). 6
  • Inflammatory or ischemic bowel disease (increases transmural contamination risk). 6
  • Frequent diverticulitis episodes. 6
  • Morbid obesity (complicates catheter placement and adequate dialysis delivery). 6
  • Severe malnutrition (compromises wound healing). 6

Safety Optimization Strategies

Infection Prevention

  • Prophylactic antibiotics before catheter placement reduce infection risk. 3
  • S. aureus nasal carriage treatment with mupirocin. 3
  • Proper exit-site care protocols. 3, 4
  • Adequate initial patient training with periodic retraining. 3, 4
  • Antifungal prophylaxis during antibiotic treatment courses. 7

Quality Monitoring

  • Continuous monitoring of infection rates (exit-site and peritonitis) is essential. 4
  • Root cause analysis of every infection episode should be routine. 4
  • Monthly patient evaluations reviewing ultrafiltration, clearance requirements, quality of life, and adherence. 1

Critical Safety Pitfalls

  • Delayed surgical intervention for peritonitis unresponsive to medical treatment can result in peritoneal membrane loss or death—surgical observation is mandatory in every peritonitis case. 5
  • Underestimating clinical symptoms of EPS leads to delayed diagnosis and worse outcomes. 5
  • Inadequate dialysis dosing increases uremic symptoms (nausea, vomiting, GI bleeding) and may increase infection risk. 1
  • Failure to monitor and address declining residual kidney function compromises overall clearance. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Peritonitis in Continuous Ambulatory Peritoneal Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surgical Complications of Peritoneal Dialysis.

Chirurgia (Bucharest, Romania : 1990), 2018

Guideline

Peritoneal Dialysis Contraindications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of peritoneal dialysis-related infections.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.